160 related articles for article (PubMed ID: 23453398)
1. Network, nodes and nexus: systems approach to multitarget therapeutics.
Murthy D; Attri KS; Gokhale RS
Curr Opin Biotechnol; 2013 Dec; 24(6):1129-36. PubMed ID: 23453398
[TBL] [Abstract][Full Text] [Related]
2. A novel algorithm for finding optimal driver nodes to target control complex networks and its applications for drug targets identification.
Guo WF; Zhang SW; Shi QQ; Zhang CM; Zeng T; Chen L
BMC Genomics; 2018 Jan; 19(Suppl 1):924. PubMed ID: 29363426
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology for cancer drug discovery: are we there yet?
Azmi AS
Future Med Chem; 2012 May; 4(8):939-41. PubMed ID: 22650234
[No Abstract] [Full Text] [Related]
4. Network systems biology for targeted cancer therapies.
Zhou TT
Chin J Cancer; 2012 Mar; 31(3):134-41. PubMed ID: 22176777
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature.
Poornima P; Kumar JD; Zhao Q; Blunder M; Efferth T
Pharmacol Res; 2016 Sep; 111():290-302. PubMed ID: 27329331
[TBL] [Abstract][Full Text] [Related]
6. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
Ozbayraktar FB; Ulgen KO
J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
8. Metabolic network modeling and simulation for drug targeting and discovery.
Kim HU; Sohn SB; Lee SY
Biotechnol J; 2012 Mar; 7(3):330-42. PubMed ID: 22125297
[TBL] [Abstract][Full Text] [Related]
9. Metabolic network adaptations in cancer as targets for novel therapies.
Cascante M; Benito A; Zanuy M; Vizán P; Marín S; de Atauri P
Biochem Soc Trans; 2010 Oct; 38(5):1302-6. PubMed ID: 20863303
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the role of network and systems biology in drug discovery.
Pujol A; Mosca R; Farrés J; Aloy P
Trends Pharmacol Sci; 2010 Mar; 31(3):115-23. PubMed ID: 20117850
[TBL] [Abstract][Full Text] [Related]
11. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies.
Du W; Elemento O
Oncogene; 2015 Jun; 34(25):3215-25. PubMed ID: 25220419
[TBL] [Abstract][Full Text] [Related]
12. Systems biology approaches and tools for analysis of interactomes and multi-target drugs.
Schrattenholz A; Groebe K; Soskic V
Methods Mol Biol; 2010; 662():29-58. PubMed ID: 20824465
[TBL] [Abstract][Full Text] [Related]
13. Regulatory networks, genes and glycerophospholipid biosynthesis pathway in schistosomiasis: a systems biology view for pharmacological intervention.
Shinde S; Mol M; Singh S
Gene; 2014 Oct; 550(2):214-22. PubMed ID: 25149020
[TBL] [Abstract][Full Text] [Related]
14. Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models.
Çubuk C; Hidalgo MR; Amadoz A; Rian K; Salavert F; Pujana MA; Mateo F; Herranz C; Carbonell-Caballero J; Dopazo J
NPJ Syst Biol Appl; 2019; 5():7. PubMed ID: 30854222
[TBL] [Abstract][Full Text] [Related]
15. A systems biology analysis of autophagy in cancer therapy.
Shi Z; Li CY; Zhao S; Yu Y; An N; Liu YX; Wu CF; Yue BS; Bao JK
Cancer Lett; 2013 Sep; 337(2):149-60. PubMed ID: 23791881
[TBL] [Abstract][Full Text] [Related]
16. Network-based drugs and biomarkers.
Erler JT; Linding R
J Pathol; 2010 Jan; 220(2):290-6. PubMed ID: 19921715
[TBL] [Abstract][Full Text] [Related]
17. Navigating cancer network attractors for tumor-specific therapy.
Creixell P; Schoof EM; Erler JT; Linding R
Nat Biotechnol; 2012 Sep; 30(9):842-8. PubMed ID: 22965061
[TBL] [Abstract][Full Text] [Related]
18. Network biology as a new approach to drug discovery.
Lowe JA; Jones P; Wilson DM
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):524-6. PubMed ID: 20812143
[TBL] [Abstract][Full Text] [Related]
19. Metabolite concentration as a criterion for antibacterial discovery.
Wang ZY; Zhu Q; Zhang HY
Curr Comput Aided Drug Des; 2013 Sep; 9(3):412-6. PubMed ID: 24010936
[TBL] [Abstract][Full Text] [Related]
20. Drug target identification through systems biology.
Haanstra JR; Bakker BM
Drug Discov Today Technol; 2015 Aug; 15():17-22. PubMed ID: 26464086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
